HCPCS Level II
J2246
Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg
Codes near J2246
These sit next to J2246 in the CMS Level II file. All J codes
- J2184Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg
- J2185Injection, meropenem, 100 mg
- J2186Injection, meropenem and vaborbactam, 10mg/10mg (20mg)
- J2210Injection, methylergonovine maleate, up to 0.2 mg
- J2212Injection, methylnaltrexone, 0.1 mg
- J2247Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg
- J2248Injection, micafungin sodium, 1 mg
- J2249Injection, remimazolam, 1 mg
- J2250Injection, midazolam hydrochloride, per 1 mg
- J2251Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00338-9051-12 | Micafungin In Sodium Chloride | Baxter Healthcare Corporation | 600 |
| 00338-9053-12 | Micafungin In Sodium Chloride | Baxter Healthcare Corporation | 1200 |
| 00338-9055-10 | Micafungin In Sodium Chloride | Baxter Healthcare Corporation | 1500 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.
Run it in Rivvi
Check every code on your export
Upload a claims or problem-list export. Rivvi flags codes that are not billable, replaced, or unspecified when a specific code exists.
Check my exportFree to start. Opens Rivvi, the AI workspace for healthcare teams.